» Articles » PMID: 38529352

Fabrication of a 3D Bioprinting Model for Posterior Capsule Opacification Using GelMA and PLMA Hydrogel-coated Resin

Overview
Journal Regen Biomater
Date 2024 Mar 26
PMID 38529352
Authors
Affiliations
Soon will be listed here.
Abstract

Posterior capsule opacification (PCO) remains the predominant complication following cataract surgery, significantly impairing visual function restoration. In this study, we developed a PCO model that closely mimics the anatomical structure of the crystalline lens capsule post-surgery. The model incorporated a threaded structure for accurate positioning and observation, allowing for opening and closing. Utilizing 3D printing technology, a stable external support system was created using resin material consisting of a rigid, hollow base and cover. To replicate the lens capsule structure, a thin hydrogel coating was applied to the resin scaffold. The biocompatibility and impact on cellular functionality of various hydrogel compositions were assessed through an array of staining techniques, including calcein-AM/PI staining, rhodamine staining, BODIPY-C11 staining and EdU staining in conjunction with transwell assays. Additionally, the PCO model was utilized to investigate the effects of eight drugs with anti-inflammatory and anti-proliferative properties, including 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), THZ1, sorbinil, 4-octyl itaconate (4-OI), xanthohumol, zebularine, rapamycin and caffeic acid phenethyl ester, on human lens epithelial cells (HLECs). Confocal microscopy facilitated comprehensive imaging of the PCO model. The results demonstrated that the GelMA 60 5% + PLMA 2% composite hydrogel exhibited superior biocompatibility and minimal lipid peroxidation levels among the tested hydrogels. Moreover, compared to using hydrogel as the material for 3D printing the entire model, applying surface hydrogel spin coating with parameters of 2000 rpm × 2 on the resin-based 3D printed base yielded a more uniform cell distribution and reduced apoptosis. Furthermore, rapamycin, 4-OI and AICAR demonstrated potent antiproliferative effects in the drug intervention study. Confocal microscopy imaging revealed a uniform distribution of HLECs along the anatomical structure of the crystalline lens capsule within the PCO model, showcasing robust cell viability and regular morphology. In conclusion, the PCO model provides a valuable experimental platform for studying PCO pathogenesis and exploring potential therapeutic interventions.

References
1.
Kurian A, Singh R, Patel K, Lee J, Kim H . Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics. Bioact Mater. 2021; 8:267-295. PMC: 8424393. DOI: 10.1016/j.bioactmat.2021.06.027. View

2.
Zhou B, Jiang X, Zhou X, Tan W, Luo H, Lei S . GelMA-based bioactive hydrogel scaffolds with multiple bone defect repair functions: therapeutic strategies and recent advances. Biomater Res. 2023; 27(1):86. PMC: 10504735. DOI: 10.1186/s40824-023-00422-6. View

3.
Rao G, Khanna R, Payal A . The global burden of cataract. Curr Opin Ophthalmol. 2010; 22(1):4-9. DOI: 10.1097/ICU.0b013e3283414fc8. View

4.
Fisus A, Findl O . Capsular fibrosis: a review of prevention methods and management. Eye (Lond). 2019; 34(2):256-262. PMC: 7002601. DOI: 10.1038/s41433-019-0723-5. View

5.
Cleary G, Spalton D, Zhang J, Marshall J . In vitro lens capsule model for investigation of posterior capsule opacification. J Cataract Refract Surg. 2010; 36(8):1249-52. DOI: 10.1016/j.jcrs.2010.05.006. View